Half of Current GLP-1 Users Say They May Have to Choose Between Medication and Retirement Savings
PR Newswire•07/10/2026•13:39 ET
1
Key Highlights
- ➤51% of current GLP-1 users worry medication costs could compete with retirement savings
- ➤54% of current users have changed financial behaviors, including debt, withdrawals, or reduced contributions
- ➤88% of current users feel more optimistic about long-term health from GLP-1 treatment
- ➤59% of current users worry about affording GLP-1 medication in retirement; average out-of-pocket cost is $203 monthly
- ➤59% expect financial professionals to advise on GLP-1 medications’ financial impact, while 47% have never discussed it
Expert Statements
Kristi Martin Rodriguez, Leader of the Nationwide Retirement Institute
“Medical innovation is changing how we think about living longer and healthier, and that's a good thing. But living longer also means your money may need to last longer”
Kristi Martin Rodriguez, Leader of the Nationwide Retirement Institute
“If what you're spending on your health today is competing with what you're saving for tomorrow, that needs to be part of the financial planning conversation.”
Kristi Martin Rodriguez, Leader of the Nationwide Retirement Institute
“The connection between health and wealth has never been more apparent than with the rise of GLP-1 medications”
Kristi Martin Rodriguez, Leader of the Nationwide Retirement Institute
“These drugs offer the potential for a longer, healthier life, but they also come with financial implications that we can't ignore. It's time to have a conversation about how the expense and benefits of these drugs impact our financial decisions today and our long-term financial outlook. Retirement savers trying to strike this balance should be intentional in creating a plan with a trusted financial advisor that keeps saving for the future on track to prepare for a longer, healthier retirement.”
Half of Current GLP-1 Users Say They May Have to Choose Between Medication and Retirement Savings PR Newswire
New Nationwide survey finds nearly nine in 10 users are optimistic about their long-term health, even as medication costs create new financial and retirement planning challenges.
Get started
Create a free account to read the full story.